127 related articles for article (PubMed ID: 31733443)
1. Combination of radiotherapy and immunotherapy for brain metastases: A systematic review and meta-analysis.
Petrelli F; De Stefani A; Trevisan F; Parati C; Inno A; Merelli B; Ghidini M; Bruschieri L; Vitali E; Cabiddu M; Borgonovo K; Ghilardi M; Barni S; Ghidini A
Crit Rev Oncol Hematol; 2019 Dec; 144():102830. PubMed ID: 31733443
[TBL] [Abstract][Full Text] [Related]
2. Combination of radiotherapy and targeted therapy for melanoma brain metastases: a systematic review.
Ge Y; Che X; Gao X; Zhao S; Su J
Melanoma Res; 2021 Oct; 31(5):413-420. PubMed ID: 34406985
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy and Immunotherapy in Melanoma Brain Metastases.
Anvari A; Sasanpour P; Kheradmardi MR
Hematol Oncol Stem Cell Ther; 2023 Jan; 16(1):1-20. PubMed ID: 36634277
[TBL] [Abstract][Full Text] [Related]
4. State of the Art in Combination Immuno/Radiotherapy for Brain Metastases: Systematic Review and Meta-Analysis.
Najafi M; Jahanbakhshi A; Gomar M; Iotti C; Giaccherini L; Rezaie O; Cavallieri F; Deantonio L; Bardoscia L; Botti A; Sardaro A; Cozzi S; Ciammella P
Curr Oncol; 2022 Apr; 29(5):2995-3012. PubMed ID: 35621634
[TBL] [Abstract][Full Text] [Related]
5. Intracranial radiotherapy with or without immune checkpoint inhibition for brain metastases: a systematic review and meta-analysis.
He Q; Zhang C; Tang S; Li J; Ren Q
Transl Cancer Res; 2020 Oct; 9(10):5909-5924. PubMed ID: 35117204
[TBL] [Abstract][Full Text] [Related]
6. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and Safety of Radiotherapy Combined with Immunotherapy
for Brain Metastases from Lung Cancer: A Meta-analysis].
Xu L; Chen Y; Wang M
Zhongguo Fei Ai Za Zhi; 2022 Oct; 25(10):715-722. PubMed ID: 36285391
[TBL] [Abstract][Full Text] [Related]
8. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
[TBL] [Abstract][Full Text] [Related]
9. The impact of timing of immunotherapy with cranial irradiation in melanoma patients with brain metastases: intracranial progression, survival and toxicity.
Rahman R; Cortes A; Niemierko A; Oh KS; Flaherty KT; Lawrence DP; Sullivan RJ; Shih HA
J Neurooncol; 2018 Jun; 138(2):299-306. PubMed ID: 29453679
[TBL] [Abstract][Full Text] [Related]
10. Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis.
Foster CC; Sher DJ; Rusthoven CG; Verma V; Spiotto MT; Weichselbaum RR; Koshy M
Radiat Oncol; 2019 Jan; 14(1):18. PubMed ID: 30691492
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: A systematic review and pooled analysis.
Petrelli F; Ghidini M; Lonati V; Tomasello G; Borgonovo K; Ghilardi M; Cabiddu M; Barni S
Eur J Cancer; 2017 Oct; 84():141-148. PubMed ID: 28810186
[TBL] [Abstract][Full Text] [Related]
12. Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis.
Galli G; Cavalieri S; Di Guardo L; Cimminiello C; Nichetti F; Corti F; Garcia MA; Pappalardi B; Fallai C; de Braud F; Platania M; Del Vecchio M
Oncol Res Treat; 2019; 42(4):186-194. PubMed ID: 30836373
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes.
Gabani P; Fischer-Valuck BW; Johanns TM; Hernandez-Aya LF; Keller JW; Rich KM; Kim AH; Dunn GP; Robinson CG; Chicoine MR; Huang J; Abraham CD
Radiother Oncol; 2018 Aug; 128(2):266-273. PubMed ID: 29960685
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials.
Xiao Z; Wang CQ; Zhou MH; Li NN; Liu SY; He YJ; Wang YZ; Feng JH; Yao XS; Chen L; Ma B; Yu S; Zeng XT; Li CW; Ding J
Int Immunopharmacol; 2018 Aug; 61():363-375. PubMed ID: 29945024
[TBL] [Abstract][Full Text] [Related]
15. Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery.
Gaudy-Marqueste C; Dussouil AS; Carron R; Troin L; Malissen N; Loundou A; Monestier S; Mallet S; Richard MA; Régis JM; Grob JJ
Eur J Cancer; 2017 Oct; 84():44-54. PubMed ID: 28783540
[TBL] [Abstract][Full Text] [Related]
16. Effects of Temozolomide and Radiotherapy on Brain Metastatic Tumor: A Systematic Review and Meta-Analysis.
Ma W; Li N; An Y; Zhou C; Bo C; Zhang G
World Neurosurg; 2016 Aug; 92():197-205. PubMed ID: 27072333
[TBL] [Abstract][Full Text] [Related]
17. Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment.
Anderson ES; Postow MA; Wolchok JD; Young RJ; Ballangrud Å; Chan TA; Yamada Y; Beal K
J Immunother Cancer; 2017 Oct; 5(1):76. PubMed ID: 29037215
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.
Blank O; von Tresckow B; Monsef I; Specht L; Engert A; Skoetz N
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007110. PubMed ID: 28447341
[TBL] [Abstract][Full Text] [Related]
19. Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis.
Zhao Q; Qin Q; Sun J; Han D; Wang Z; Teng J; Li B
PLoS One; 2016; 11(3):e0150419. PubMed ID: 26930609
[TBL] [Abstract][Full Text] [Related]
20. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
